Methylprednisolone pulse therapy promotes the differentiation of regulatory T cells by inducing the apoptosis of CD4+ T cells in patients with systemic lupus erythematosus-Reference-Cited by-同舟云学术

Methylprednisolone pulse therapy promotes the differentiation of regulatory T cells by inducing the apoptosis of CD4+ T cells in patients with systemic lupus erythematosus

Published:2022-08 Issue: Volume:241 Page:109079
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Sun Jin-lei,Lyu Tai-biao,Chen Zhi-lei,Lian Chao-feng,Liu Su-ying,Shao Ti-hong,Zhang Shuo,Zhao Li-ling,Liu Jin-jing,Peng Lin-yi,Zhang Li,Yang Yun-jiao,Zhang Feng-chun,Chen Hua

Funder

Fundamental Research Funds for the Central Universities

National Natural Science Foundation of China

Chinese Academy of Meteorological Sciences

National Key Research and Development Program of China

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference27 articles.

1. Genomic and nongenomic effects of glucocorticoids;Stahn;Nat. Clin. Pract. Rheumatol.,2008

2. Apoptosis induction in human peripheral blood T lymphocytes by high-dose steroid therapy;Migita;Transplantation,1997

3. Phagocytosis of apoptotic cells in homeostasis;Arandjelovic;Nat. Immunol.,2015

4. TGF-beta released by apoptotic T cells contributes to an immunosuppressive milieu;Chen;Immunity,2001

5. Differential effects of apoptotic versus lysed cells on macrophage production of cytokines: role of proteases;Fadok;J. Immunol.,2001

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reverse vaccinology approach for identification of epitopes from E1 protein as peptide vaccine against HCV: A proof of concept;Vaccine;2024-10

2. Intermittent pulses of methylprednisolone with low-dose prednisone attenuate lupus symptoms in B6.MRL-Faslpr/J mice with fewer glucocorticoid side effects;Biomedicine & Pharmacotherapy;2024-08

3. Pathogenesis and novel therapeutics of regulatory T cell subsets and interleukin-2 therapy in systemic lupus erythematosus;Frontiers in Immunology;2023-09-12